Research output per year
Research output per year
Personal profile
Headline
LECTURER | Population Health Science and Policy
Fingerprint
Dive into the research topics where Lopa Gupta is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 19 Article
-
Permanent Pacemaker Implantation and Long-Term Outcomes of Patients Undergoing Concomitant Mitral and Tricuspid Valve Surgery
Iribarne, A., Alabbadi, S. H., Moskowitz, A. J., Ailawadi, G., Badhwar, V., Gillinov, M., Thourani, V. H., Allen, K. B., Halkos, M. E., Patel, N. C., Kramer, R. S., D'Alessandro, D., Raymond, S., Chang, H. L., Gupta, L., Fenton, K. N., Taddei-Peters, W. C., Chu, M. W. A., Falk, V. & Chikwe, J. & 5 others, , 30 Apr 2024, In: Journal of the American College of Cardiology. 83, 17, p. 1656-1668 13 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
The impact of perioperative stroke and delirium on outcomes after surgical aortic valve replacement
Cardiothoracic Surgical Trials Network (CTSN) Investigators, Feb 2024, In: Journal of Thoracic and Cardiovascular Surgery. 167, 2, p. 624-633.e4Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial
ACTIV-3b/Therapeutics for Severely Ill Inpatients with COVID-19 (TESICO) Study Group, Sep 2023, In: The Lancet Respiratory Medicine. 11, 9, p. 791-803 13 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial
ACTIV-3/Therapeutics for Inpatients with COVID-19 (TICO) Study Group, May 2022, In: The Lancet Infectious Diseases. 22, 5, p. 622-635 14 p.Research output: Contribution to journal › Article › peer-review
Open Access146 Scopus citations -
Rationale and design of a randomized trial evaluating an external support device for saphenous vein coronary grafts
Bagiella, E., Puskas, J. D., Moskowitz, A. J., Gelijns, A. C., Alexander, J. H., Narula, J., Smith, P. K., Hutcheson, K., Chang, H. L., Gammie, J. S., Iribarne, A., Marks, M. E., Vengrenyuk, Y., Yasumura, K., Raymond, S., Taylor, B. S., Yarden, O., Orion, E., Dagenais, F. & Ailawadi, G. & 14 others, , Apr 2022, In: American Heart Journal. 246, p. 12-20 9 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations
Press/Media
-
Investigators at Icahn School of Medicine at Mount Sinai Detail Findings in Heart Disease (Permanent Pacemaker Implantation and Long-term Outcomes of Patients Undergoing Concomitant Mitral and Tricuspid Valve Surgery)
Chikwe, , J., Moskowitz, A., Bagiella, E. & Gupta, L.
5/07/24
1 item of Media coverage
Press/Media